Skip to main content
EHTH
NASDAQ Finance

eHealth Reports Q1 GAAP Net Loss, Misses EPS, but Delivers Strong Operating Cash Flow and Reiterates FY26 Guidance

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Insurance Stocks · Financial
Sentiment info
Neutral
Importance info
7
Price
$1.75
Mkt Cap
$62.146M
52W Low
$1.197
52W High
$7.09
52W Position info
46% above low
Off High info
75% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

EHTH sits 46% above its 52-week low of $1.197.

Summary

eHealth, Inc. reported a Q1 GAAP net loss of $4.7 million and missed analyst EPS estimates, but generated significant operating cash flow of $35.8 million and reiterated its full-year 2026 guidance, alongside a director resignation.


Key Events · Earnings and Guidance · EHTH

  • Q1 2026 Financial Results

    Reported a GAAP net loss of $4.7 million and an EPS loss of $0.58, missing analyst estimates of a $0.28 loss per share. Total revenue decreased 22% year-over-year to $88.0 million.

  • Strong Operating Cash Flow

    Generated $35.8 million in operating cash flow for Q1 2026, demonstrating significant liquidity and financial strength relative to the company's market capitalization.

  • Reiterated FY 2026 Guidance

    Maintained full-year guidance for revenue, GAAP net income, adjusted EBITDA, and operating cash flow, indicating management's confidence in achieving its strategic objectives and cost reduction targets.

  • Operational Improvements & Cost Reductions

    Achieved a 16% decrease in total operating costs and expenses, with a target of $90 million in total FY 2026 operating cost reductions, alongside improved Medicare unit economics and LTV-to-CAC ratio.


Analysis · EHTH · Finance

While eHealth reported a GAAP net loss of $4.7 million and missed analyst EPS estimates for Q1 2026, the filing highlights several positive operational and financial developments. The company generated a substantial $35.8 million in operating cash flow, which is a strong indicator of liquidity and financial health, especially for a company with a market capitalization of approximately $62 million. Management also reiterated its full-year 2026 guidance, signaling confidence in future performance and its strategic initiatives, including a target of $90 million in operating cost reductions. Improved Medicare unit economics and the launch of new offerings further support the long-term strategy. The director's resignation is noted as non-dispute related, mitigating its impact. Investors should weigh the current GAAP loss against the strong cash generation and positive forward-looking operational improvements.

At the time of this filing, EHTH was trading at $1.75 on NASDAQ in the Finance sector, with a market capitalization of approximately $62.1M. The 52-week trading range was $1.20 to $7.09. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

EHTH - Latest Insights

EHTH
Jun 25, 2026, 4:14 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.59
Real-time Price: $1.33 info
Change: -$0.260 (-16%) info
Market Cap: $42.216M info
EHTH
Jun 04, 2026, 9:00 AM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $1.51
Real-time Price: $1.33 info
Change: -$0.177 (-12%) info
Market Cap: $42.216M info
EHTH
May 07, 2026, 6:11 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $1.99
Real-time Price: $1.33 info
Change: -$0.660 (-33%) info
Market Cap: $42.216M info
EHTH
May 04, 2026, 5:45 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $1.90
Real-time Price: $1.33 info
Change: -$0.570 (-30%) info
Market Cap: $42.216M info
EHTH
Apr 28, 2026, 4:16 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $1.93
Real-time Price: $1.33 info
Change: -$0.600 (-31%) info
Market Cap: $42.216M info